Latest Innovation News

MetalsGrove Mining has significantly expanded its landholding in Côte d’Ivoire to 1,315 km² through a new joint venture and permit grant, commencing soil sampling with results due early 2026. The company also secured $2.7 million in oversubscribed funding to accelerate exploration.

Xamble Group Limited has reported a second consecutive quarter of strong revenue growth, driven by rapid expansion in its influencer community and social commerce transactions. The company’s improving EBITDA and strategic financing moves position it well for sustained growth in 2026.

Adveritas Limited has reported a record $14.25 million annualised recurring revenue for the December 2025 quarter, driven by strong US market growth and AI-enhanced product development. The company’s strategic focus on media agency partnerships and new product lines signals robust momentum ahead.

Imricor Medical Systems has secured Virginia Commonwealth University Health as the third US site for its VISABL-AFL clinical trial, advancing its FDA approval pathway for MRI-guided cardiac ablation technology.

Praemium Limited reported a 14% year-on-year increase in total Funds Under Administration to $70.5 billion for Q2 FY26, completing the OneVue transition and seeing strong net inflows in its Spectrum and Powerwrap platforms.

Algorae Pharmaceuticals has locked in a $3 million revolving debt facility with ScotPac, providing flexible, non-dilutive funding to accelerate its commercial operations across Australia and New Zealand.

Noxopharm has successfully completed the final multiple-dose cohort of its HERACLES trial for SOF-SKN™, reporting no significant safety concerns and paving the way for Phase II-enabling studies.

BCAL Diagnostics has launched its Avantect pancreatic and ovarian cancer tests in Australia, alongside expanding clinical data and establishing a national registry for its BREASTESTplus breast cancer test.

AdAlta Limited has aligned its AdCella manufacturing strategy with new US FDA guidelines, made a significant milestone payment to Shanghai Cell Therapy Group, and secured an additional R&D tax rebate, marking key progress in its cellular immunotherapy pipeline.

Anteris Technologies has launched a $200 million public offering alongside a $90 million strategic investment from Medtronic, aiming to accelerate its DurAVR heart valve clinical trials and manufacturing expansion.

Firebrick Pharma has introduced its Nasodine Throat Spray in Singapore, marking its first international product launch and setting the stage for further global rollouts in 2026.

Everest Metals Corporation, in partnership with Edith Cowan University, has won a $490,500 grant to accelerate its innovative rubidium extraction technology at the Mt Edon project, positioning Australia to establish its first sovereign rubidium supply.